Journey to complete remission of dysplasia and intestinal metaplasia after ESD and EMR of Barrett’s esophagus-related neoplasia
Endoscopy International Open · 12.05.2025 · 13 (CP)
DOI: 10.1055/a-2422-2815 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy International Open, erschienen am 12.05.2025. Verfasst von Abel Joseph und 11 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, Cleveland Clinic Foundation, Cleveland, United States. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Although endoscopic submucosal dissection (ESD) is associated with higher en-bloc and R0 resection rates than cap-assisted endoscopic mucosal resection (cEMR), its comparative impact on achieving complete remission of dysplasia (CRD) and intestinal metaplasia (CRIM) in BE endoscopic eradication therapy (EET) is not well defined. We aimed to compare the journey of patients from initial endoscopic resection (ER) with ESD and cEMR to achieving CRD and CRIM. Patients undergoing ESD or cEMR followed by ablation for BE neoplasia at two academic institutions in the United States were included. Primary outcomes included CRD and CRIM rates following ER in the two groups. Secondary outcomes included the number of resection/ablative procedures from initial ER to achieving CRD and CRIM. Inverse probability treatment weighting (IPTW) was used to balance confounding variables between groups. A total of 801 patients (606 cEMR, 195 ESD) were included. ESD group patients had higher en-bloc resection rates (ESD 94.4%, cEMR 44.7%). Higher rates of CRD were observed in patients undergoing initial ESD (HR 1.53, P < 0.01). With time-to-event and IPTW analyses, rates of achieving CRD and CRIM were comparable between the groups. There were no significant differences in mean number of endoscopic resection or ablative procedures among patients undergoing initial cEMR resection compared with those treated with initial ESD. Despite larger lesion sizes and more cancers in patients undergoing ESD, the EET journey to achieving CRD and CRIM was comparable to that in patients receiving cEMR. Prospective studies are required to further study differences between these two treatment approaches.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Internal Medicine, Cleveland Clinic Foundation, Cleveland, United States.
- Division of Gastroenterology and Hepatology, Stanford University, Stanford, United States.
- Barrett's Esophagus Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, United States.
- Biostatistics, Mayo Clinic, Rochester, MN, USA, Rochester, United States.
- Section of Therapeutic Endoscopy, Department of Gastroenterology and Hepatology, Digestive Disease Surgical Institute, Cleveland Clinic Foundation, Cleveland, United States.
- Section of Therapeutic Endoscopy, Department of Gastroenterology and Hepatology, Digestive Disease Surgical Institute, Cleveland Clinic, Cleveland, United States.
ORCID-Profile: Abel Joseph
Zitieren
APA
Joseph, A., Vantanasiri, K., Goyal, R., Garg, N., Leggett, C., Codipilly, D. C., Wang, K., Harmsen, W. S., Vargo, J. J., Jang, S., Iyer, P., & Bhatt, A. (2025). Journey to complete remission of dysplasia and intestinal metaplasia after ESD and EMR of Barrett’s esophagus-related neoplasia. Endoscopy International Open, 13(CP). https://doi.org/10.1055/a-2422-2815
Vancouver
Joseph A, Vantanasiri K, Goyal R, Garg N, Leggett C, Codipilly DC, et al. Journey to complete remission of dysplasia and intestinal metaplasia after ESD and EMR of Barrett’s esophagus-related neoplasia. Endoscopy International Open. 2025;13(CP). doi:10.1055/a-2422-2815
BibTeX
@article{Joseph2025,
author = {Joseph, Abel and Vantanasiri, Kornpong and Goyal, Rohit and Garg, Nikita and Leggett, Cadman and Codipilly, D Chamil and Wang, Kenneth and Harmsen, William S and Vargo, John J and Jang, Sunguk and Iyer, Prasad and Bhatt, Amit},
title = {Journey to complete remission of dysplasia and intestinal metaplasia after ESD and EMR of Barrett’s esophagus-related neoplasia},
journal = {Endoscopy International Open},
year = {2025},
volume = {13},
number = {CP},
doi = {10.1055/a-2422-2815}
}
EUVIMED